Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Jing Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-2199-8623; OpenAlex author ID A5101912333. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2024-334361↗
  2. Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. Co-author DOI 10.1038/s41416-024-02631-9↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Xu · 2 shared papers, 2024–2025 · strength 0.45
  2. Mingming Xiao · 2 shared papers, 2024–2025 · strength 0.45
  3. Xianjun Yu · 2 shared papers, 2024–2025 · strength 0.45
  4. Si Shi · 2 shared papers, 2024–2025 · strength 0.45
  5. Xu He · 1 shared paper, 2025 · strength 0.24
  6. Zhen Tan · 1 shared paper, 2025 · strength 0.24
  7. Xiaoqi Mao · 1 shared paper, 2024 · strength 0.21
  8. Di Wu · 1 shared paper, 2024 · strength 0.21
  9. Yalan Lei · 1 shared paper, 2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.